• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOT 5.17% 27.5¢

BOTANIX PHARMACEUTICALS LTD - Announcements

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

Announcements


BOT Appendix 3B and Notice Under Section 708A27/06/18 download Created with Sketch. 222.55KB
BOT First Patients Recruited into BTX 1503 Phase 2 Acne TrialPRICE SENSITIVE27/06/18 download Created with Sketch. 110.99KB
BOT BOT Welcomes First FDA Approval for Cannabidiol ProductPRICE SENSITIVE26/06/18 download Created with Sketch. 139.87KB
BOT Botanix Raises A$8m in Oversubscribed PlacementPRICE SENSITIVE20/06/18 download Created with Sketch. 110.13KB
BOT Trading HaltPRICE SENSITIVE18/06/18 download Created with Sketch. 434.33KB
BOT Australian Ethics approval for Acne StudyPRICE SENSITIVE13/06/18 download Created with Sketch. 107.55KB
BOT Investor Presentation12/06/18 download Created with Sketch. 1.07MB
BOT BTX 1204 Atopic Dermatitis Study Results PresentationPRICE SENSITIVE07/06/18 download Created with Sketch. 804.09KB
BOT Botanix Announces Successful Atopic Dermatitis Study ResultsPRICE SENSITIVE06/06/18 download Created with Sketch. 138.5KB
BOT Trading HaltPRICE SENSITIVE05/06/18 download Created with Sketch. 281.47KB
BOT Presentation on Atopic Dermatitis MarketPRICE SENSITIVE23/05/18 download Created with Sketch. 801.83KB
BOT BOT Presents BTX 1503 Data at International Dermatology Meet18/05/18 download Created with Sketch. 126.96KB
BOT Results of Meeting11/05/18 download Created with Sketch. 387.64KB
BOT Appendix 3B and Notice Under Section 708A09/05/18 download Created with Sketch. 165.2KB
BOT FDA Green Light for BTX 1503 Phase 2 StudyPRICE SENSITIVE08/05/18 download Created with Sketch. 108.88KB
BOT Change of Director's Interest Notice * 401/05/18 download Created with Sketch. 150.51KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE24/04/18 download Created with Sketch. 371.31KB
BOT Notice of General Meeting/Proxy Form12/04/18 download Created with Sketch. 209.8KB
BOT Investor Presentation09/04/18 download Created with Sketch. 1.21MB
BOT Enrolment of BTX 1204 Atopic Dermatitis Study CompletedPRICE SENSITIVE09/04/18 download Created with Sketch. 131.02KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE26/02/18 download Created with Sketch. 680.59KB
BOT American Academy of Dermatology Annual Meeting Presentation15/02/18 download Created with Sketch. 924.56KB
BOT Change in substantial holding14/02/18 download Created with Sketch. 528.05KB
BOT Change in substantial holding14/02/18 download Created with Sketch. 39.89KB
BOT Appendix 3B and Notice Under Section 708A12/02/18 download Created with Sketch. 167.21KB
BOT Completion of PlacementPRICE SENSITIVE12/02/18 download Created with Sketch. 148.38KB
BOT Appendix 3B and Notice Under Section 708A07/02/18 download Created with Sketch. 166.27KB
BOT Investor Presentation05/02/18 download Created with Sketch. 2.46MB
BOT Significantly Oversubscribed A$15m PlacementPRICE SENSITIVE05/02/18 download Created with Sketch. 138.07KB
BOT Trading HaltPRICE SENSITIVE01/02/18 download Created with Sketch. 325.12KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 184.6KB
BOT Botanix Announces Successful Acne Study ResultsPRICE SENSITIVE29/01/18 download Created with Sketch. 138.55KB
BOT Trading HaltPRICE SENSITIVE24/01/18 download Created with Sketch. 303.29KB
BOT Presentation to Botanix Advisory Board22/01/18 download Created with Sketch. 365.73KB
BOT Botanix Receives A$1.6m R&D Tax Incentive RefundPRICE SENSITIVE16/01/18 download Created with Sketch. 100.73KB
BOT Botanix Presents at San Francisco Dermatology Summit08/01/18 download Created with Sketch. 2.01MB
BOT Botanix Completes Enrolment of BTX 1503 Acne Patient StudyPRICE SENSITIVE18/12/17 download Created with Sketch. 105.47KB
BOT Botanix BTX 1204 Study featured on 7News07/12/17 download Created with Sketch. 101.83KB
BOT New Antibacterial Results Support BTX 1503 Acne ProgramPRICE SENSITIVE05/12/17 download Created with Sketch. 152.99KB
BOT Botanix Enrols First Patients in Dermatitis StudyPRICE SENSITIVE23/11/17 download Created with Sketch. 106.02KB
BOT Results of Meeting14/11/17 download Created with Sketch. 93.94KB
BOT 2017 Annual General Meeting Chairmans Address14/11/17 download Created with Sketch. 434.3KB
BOT Investor Presentation13/11/17 download Created with Sketch. 1.94MB
BOT Appendix 4C - quarterlyPRICE SENSITIVE31/10/17 download Created with Sketch. 607.2KB
BOT Botanix Commences BTX 1204 Dermatitis Patient StudyPRICE SENSITIVE31/10/17 download Created with Sketch. 109.18KB
BOT Notice of Annual General Meeting/Proxy Form13/10/17 download Created with Sketch. 964.67KB
BOT FDA Clears Development Path for BTX 1503PRICE SENSITIVE09/10/17 download Created with Sketch. 108.76KB
BOT Appendix 4G21/09/17 download Created with Sketch. 111.23KB
BOT Annual Report to shareholders21/09/17 download Created with Sketch. 1.35MB
BOT Preliminary Final ReportPRICE SENSITIVE30/08/17 download Created with Sketch. 891.86KB
BOT Botanix Commences BTX 1503 Acne Patient StudyPRICE SENSITIVE21/08/17 download Created with Sketch. 280.16KB
BOT Trading HaltPRICE SENSITIVE17/08/17 download Created with Sketch. 135.8KB
BOT Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 326.76KB
BOT Company Presentation11/07/17 download Created with Sketch. 1.92MB
BOT Botanix Completes Successful Phase 1 BTX 1503 Clinical StudyPRICE SENSITIVE03/07/17 download Created with Sketch. 414.79KB
BOT Trading HaltPRICE SENSITIVE30/06/17 download Created with Sketch. 574.2KB
BOT 12 Month Operational Review Highlights Significant ProgressPRICE SENSITIVE27/06/17 download Created with Sketch. 576.07KB
BOT Successful Pilot Study for BTX 1701 Facial CleanserPRICE SENSITIVE08/06/17 download Created with Sketch. 507.57KB
BOT Completion of Tranche 2 of Capital Raising PlacementPRICE SENSITIVE19/05/17 download Created with Sketch. 404.09KB
BOT Appendix 3B19/05/17 download Created with Sketch. 733.04KB
BOT Results of Meeting15/05/17 download Created with Sketch. 387.98KB
BOT Appendix 3B09/05/17 download Created with Sketch. 834.04KB
BOT Botanix Commences First Clinical Study for BTX 1503PRICE SENSITIVE08/05/17 download Created with Sketch. 487.7KB
BOT Botanix Presents at Investor Seminar04/05/17 download Created with Sketch. 5.1MB
BOT Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 1.58MB
BOT Notice of General Meeting/Proxy Form13/04/17 download Created with Sketch. 1.44MB
BOT Change in substantial holding13/04/17 download Created with Sketch. 107.29KB
BOT Change in substantial holding13/04/17 download Created with Sketch. 569.18KB
BOT Appendix 3B12/04/17 download Created with Sketch. 734.54KB
BOT Completion of the Tranche 1 PlacementPRICE SENSITIVE12/04/17 download Created with Sketch. 429.35KB
BOT Reinstatement to official quotationPRICE SENSITIVE05/04/17 download Created with Sketch. 273.25KB
BOT Capital Raising Presentation05/04/17 download Created with Sketch. 1.46MB
BOT Botanix Raises A$7.4 Million in Oversubscribed PlacementPRICE SENSITIVE05/04/17 download Created with Sketch. 282.75KB
BOT Suspension from Official QuotationPRICE SENSITIVE04/04/17 download Created with Sketch. 567.17KB
BOT Trading HaltPRICE SENSITIVE31/03/17 download Created with Sketch. 671.99KB
BOT Botanix Receives Approval for Synthetic Cannabidiol TrialPRICE SENSITIVE30/03/17 download Created with Sketch. 387.64KB
BOT Export and Import Approvals for Clinical Studies ReceivedPRICE SENSITIVE24/03/17 download Created with Sketch. 95.57KB
BOT Company Update22/03/17 download Created with Sketch. 1.49MB
BOT Response to ASX Price QueryPRICE SENSITIVE13/03/17 download Created with Sketch. 494.35KB
BOT American Academy of Dermatology Annual Meeting Presentation06/03/17 download Created with Sketch. 6.13MB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/17 download Created with Sketch. 1.62MB
BOT Botanix Announces Filing of New Permetrex Product PatentsPRICE SENSITIVE27/02/17 download Created with Sketch. 95.48KB
BOT Change of Company Secretary and Registered Office17/02/17 download Created with Sketch. 80.53KB
BOT Botanix Expands Management Team14/02/17 download Created with Sketch. 94.57KB
BOT Botanix Announces Expansion of Permetrex LicensePRICE SENSITIVE03/02/17 download Created with Sketch. 258.58KB
BOT Quarterly Cashflow ReportPRICE SENSITIVE30/01/17 download Created with Sketch. 746.29KB
BOT Botanix Issues Options Under Incentive Plan20/01/17 download Created with Sketch. 892.66KB
BOT Change of Director's Interest Notice04/01/17 download Created with Sketch. 312.29KB
BOT Change of Share Registry Address09/12/16 download Created with Sketch. 208.53KB
BOT Botanix Announces Positive Human Trial DataPRICE SENSITIVE07/12/16 download Created with Sketch. 260.31KB
BOT Amended Change of Director's Interest Notice05/12/16 download Created with Sketch. 583.34KB
BOT Change of Director's Interest Notice x 305/12/16 download Created with Sketch. 644.18KB
BOT Appendix 3B01/12/16 download Created with Sketch. 681.21KB
BOT Results of Annual General Meeting30/11/16 download Created with Sketch. 242.78KB
BOT AGM Investor Presentation30/11/16 download Created with Sketch. 5.2MB
BOT Chairman's Address to the AGM30/11/16 download Created with Sketch. 258.55KB
BOT Botanix Accelerates Clinical Program with First Human StudyPRICE SENSITIVE11/11/16 download Created with Sketch. 262.55KB
BOT Quarterly Cashflow Report-BOT.AX PRICE SENSITIVE31/10/16 download Created with Sketch. 552.41KB
BOT Change of Director's Interest Notice-BOT.AX 26/10/16 download Created with Sketch. 20.96KB
BOT Notice of Annual General Meeting-BOT.AX 20/10/16 download Created with Sketch. 377.94KB
BOT Appendix 3B and Notice Under Section 708A
27/06/18 download Created with Sketch. 222.55KB
BOT First Patients Recruited into BTX 1503 Phase 2 Acne Trial
27/06/18PRICE SENSITIVE download Created with Sketch. 110.99KB
BOT BOT Welcomes First FDA Approval for Cannabidiol Product
26/06/18PRICE SENSITIVE download Created with Sketch. 139.87KB
BOT Botanix Raises A$8m in Oversubscribed Placement
20/06/18PRICE SENSITIVE download Created with Sketch. 110.13KB
BOT Trading Halt
18/06/18PRICE SENSITIVE download Created with Sketch. 434.33KB
BOT Australian Ethics approval for Acne Study
13/06/18PRICE SENSITIVE download Created with Sketch. 107.55KB
BOT Investor Presentation
12/06/18 download Created with Sketch. 1.07MB
BOT BTX 1204 Atopic Dermatitis Study Results Presentation
07/06/18PRICE SENSITIVE download Created with Sketch. 804.09KB
BOT Botanix Announces Successful Atopic Dermatitis Study Results
06/06/18PRICE SENSITIVE download Created with Sketch. 138.5KB
BOT Trading Halt
05/06/18PRICE SENSITIVE download Created with Sketch. 281.47KB
BOT Presentation on Atopic Dermatitis Market
23/05/18PRICE SENSITIVE download Created with Sketch. 801.83KB
BOT BOT Presents BTX 1503 Data at International Dermatology Meet
18/05/18 download Created with Sketch. 126.96KB
BOT Results of Meeting
11/05/18 download Created with Sketch. 387.64KB
BOT Appendix 3B and Notice Under Section 708A
09/05/18 download Created with Sketch. 165.2KB
BOT FDA Green Light for BTX 1503 Phase 2 Study
08/05/18PRICE SENSITIVE download Created with Sketch. 108.88KB
BOT Change of Director's Interest Notice * 4
01/05/18 download Created with Sketch. 150.51KB
BOT Appendix 4C - quarterly
24/04/18PRICE SENSITIVE download Created with Sketch. 371.31KB
BOT Notice of General Meeting/Proxy Form
12/04/18 download Created with Sketch. 209.8KB
BOT Investor Presentation
09/04/18 download Created with Sketch. 1.21MB
BOT Enrolment of BTX 1204 Atopic Dermatitis Study Completed
09/04/18PRICE SENSITIVE download Created with Sketch. 131.02KB
BOT Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE download Created with Sketch. 680.59KB
BOT American Academy of Dermatology Annual Meeting Presentation
15/02/18 download Created with Sketch. 924.56KB
BOT Change in substantial holding
14/02/18 download Created with Sketch. 528.05KB
BOT Change in substantial holding
14/02/18 download Created with Sketch. 39.89KB
BOT Appendix 3B and Notice Under Section 708A
12/02/18 download Created with Sketch. 167.21KB
BOT Completion of Placement
12/02/18PRICE SENSITIVE download Created with Sketch. 148.38KB
BOT Appendix 3B and Notice Under Section 708A
07/02/18 download Created with Sketch. 166.27KB
BOT Investor Presentation
05/02/18 download Created with Sketch. 2.46MB
BOT Significantly Oversubscribed A$15m Placement
05/02/18PRICE SENSITIVE download Created with Sketch. 138.07KB
BOT Trading Halt
01/02/18PRICE SENSITIVE download Created with Sketch. 325.12KB
BOT Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 184.6KB
BOT Botanix Announces Successful Acne Study Results
29/01/18PRICE SENSITIVE download Created with Sketch. 138.55KB
BOT Trading Halt
24/01/18PRICE SENSITIVE download Created with Sketch. 303.29KB
BOT Presentation to Botanix Advisory Board
22/01/18 download Created with Sketch. 365.73KB
BOT Botanix Receives A$1.6m R&D Tax Incentive Refund
16/01/18PRICE SENSITIVE download Created with Sketch. 100.73KB
BOT Botanix Presents at San Francisco Dermatology Summit
08/01/18 download Created with Sketch. 2.01MB
BOT Botanix Completes Enrolment of BTX 1503 Acne Patient Study
18/12/17PRICE SENSITIVE download Created with Sketch. 105.47KB
BOT Botanix BTX 1204 Study featured on 7News
07/12/17 download Created with Sketch. 101.83KB
BOT New Antibacterial Results Support BTX 1503 Acne Program
05/12/17PRICE SENSITIVE download Created with Sketch. 152.99KB
BOT Botanix Enrols First Patients in Dermatitis Study
23/11/17PRICE SENSITIVE download Created with Sketch. 106.02KB
BOT Results of Meeting
14/11/17 download Created with Sketch. 93.94KB
BOT 2017 Annual General Meeting Chairmans Address
14/11/17 download Created with Sketch. 434.3KB
BOT Investor Presentation
13/11/17 download Created with Sketch. 1.94MB
BOT Appendix 4C - quarterly
31/10/17PRICE SENSITIVE download Created with Sketch. 607.2KB
BOT Botanix Commences BTX 1204 Dermatitis Patient Study
31/10/17PRICE SENSITIVE download Created with Sketch. 109.18KB
BOT Notice of Annual General Meeting/Proxy Form
13/10/17 download Created with Sketch. 964.67KB
BOT FDA Clears Development Path for BTX 1503
09/10/17PRICE SENSITIVE download Created with Sketch. 108.76KB
BOT Appendix 4G
21/09/17 download Created with Sketch. 111.23KB
BOT Annual Report to shareholders
21/09/17 download Created with Sketch. 1.35MB
BOT Preliminary Final Report
30/08/17PRICE SENSITIVE download Created with Sketch. 891.86KB
BOT Botanix Commences BTX 1503 Acne Patient Study
21/08/17PRICE SENSITIVE download Created with Sketch. 280.16KB
BOT Trading Halt
17/08/17PRICE SENSITIVE download Created with Sketch. 135.8KB
BOT Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 326.76KB
BOT Company Presentation
11/07/17 download Created with Sketch. 1.92MB
BOT Botanix Completes Successful Phase 1 BTX 1503 Clinical Study
03/07/17PRICE SENSITIVE download Created with Sketch. 414.79KB
BOT Trading Halt
30/06/17PRICE SENSITIVE download Created with Sketch. 574.2KB
BOT 12 Month Operational Review Highlights Significant Progress
27/06/17PRICE SENSITIVE download Created with Sketch. 576.07KB
BOT Successful Pilot Study for BTX 1701 Facial Cleanser
08/06/17PRICE SENSITIVE download Created with Sketch. 507.57KB
BOT Completion of Tranche 2 of Capital Raising Placement
19/05/17PRICE SENSITIVE download Created with Sketch. 404.09KB
BOT Appendix 3B
19/05/17 download Created with Sketch. 733.04KB
BOT Results of Meeting
15/05/17 download Created with Sketch. 387.98KB
BOT Appendix 3B
09/05/17 download Created with Sketch. 834.04KB
BOT Botanix Commences First Clinical Study for BTX 1503
08/05/17PRICE SENSITIVE download Created with Sketch. 487.7KB
BOT Botanix Presents at Investor Seminar
04/05/17 download Created with Sketch. 5.1MB
BOT Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 1.58MB
BOT Notice of General Meeting/Proxy Form
13/04/17 download Created with Sketch. 1.44MB
BOT Change in substantial holding
13/04/17 download Created with Sketch. 107.29KB
BOT Change in substantial holding
13/04/17 download Created with Sketch. 569.18KB
BOT Appendix 3B
12/04/17 download Created with Sketch. 734.54KB
BOT Completion of the Tranche 1 Placement
12/04/17PRICE SENSITIVE download Created with Sketch. 429.35KB
BOT Reinstatement to official quotation
05/04/17PRICE SENSITIVE download Created with Sketch. 273.25KB
BOT Capital Raising Presentation
05/04/17 download Created with Sketch. 1.46MB
BOT Botanix Raises A$7.4 Million in Oversubscribed Placement
05/04/17PRICE SENSITIVE download Created with Sketch. 282.75KB
BOT Suspension from Official Quotation
04/04/17PRICE SENSITIVE download Created with Sketch. 567.17KB
BOT Trading Halt
31/03/17PRICE SENSITIVE download Created with Sketch. 671.99KB
BOT Botanix Receives Approval for Synthetic Cannabidiol Trial
30/03/17PRICE SENSITIVE download Created with Sketch. 387.64KB
BOT Export and Import Approvals for Clinical Studies Received
24/03/17PRICE SENSITIVE download Created with Sketch. 95.57KB
BOT Company Update
22/03/17 download Created with Sketch. 1.49MB
BOT Response to ASX Price Query
13/03/17PRICE SENSITIVE download Created with Sketch. 494.35KB
BOT American Academy of Dermatology Annual Meeting Presentation
06/03/17 download Created with Sketch. 6.13MB
BOT Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE download Created with Sketch. 1.62MB
BOT Botanix Announces Filing of New Permetrex Product Patents
27/02/17PRICE SENSITIVE download Created with Sketch. 95.48KB
BOT Change of Company Secretary and Registered Office
17/02/17 download Created with Sketch. 80.53KB
BOT Botanix Expands Management Team
14/02/17 download Created with Sketch. 94.57KB
BOT Botanix Announces Expansion of Permetrex License
03/02/17PRICE SENSITIVE download Created with Sketch. 258.58KB
BOT Quarterly Cashflow Report
30/01/17PRICE SENSITIVE download Created with Sketch. 746.29KB
BOT Botanix Issues Options Under Incentive Plan
20/01/17 download Created with Sketch. 892.66KB
BOT Change of Director's Interest Notice
04/01/17 download Created with Sketch. 312.29KB
BOT Change of Share Registry Address
09/12/16 download Created with Sketch. 208.53KB
BOT Botanix Announces Positive Human Trial Data
07/12/16PRICE SENSITIVE download Created with Sketch. 260.31KB
BOT Amended Change of Director's Interest Notice
05/12/16 download Created with Sketch. 583.34KB
BOT Change of Director's Interest Notice x 3
05/12/16 download Created with Sketch. 644.18KB
BOT Appendix 3B
01/12/16 download Created with Sketch. 681.21KB
BOT Results of Annual General Meeting
30/11/16 download Created with Sketch. 242.78KB
BOT AGM Investor Presentation
30/11/16 download Created with Sketch. 5.2MB
BOT Chairman's Address to the AGM
30/11/16 download Created with Sketch. 258.55KB
BOT Botanix Accelerates Clinical Program with First Human Study
11/11/16PRICE SENSITIVE download Created with Sketch. 262.55KB
BOT Quarterly Cashflow Report-BOT.AX
31/10/16PRICE SENSITIVE download Created with Sketch. 552.41KB
BOT Change of Director's Interest Notice-BOT.AX
26/10/16 download Created with Sketch. 20.96KB
BOT Notice of Annual General Meeting-BOT.AX
20/10/16 download Created with Sketch. 377.94KB
(20min delay)
Last
27.5¢
Change
-0.015(5.17%)
Mkt cap ! $433.1M
Open High Low Value Volume
28.5¢ 29.0¢ 27.5¢ $1.164M 4.100M

Buyers (Bids)

No. Vol. Price($)
9 534239 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 77302 2
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
28.0¢
  Change
-0.015 ( 2.61 %)
Open High Low Volume
28.5¢ 29.0¢ 27.5¢ 2348390
Last updated 15.59pm 28/05/2024 ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.